In addition, another advantage of the current study is simultaneous measurements of several adipocytokines for the first time and the evaluation their cross-talk with key inflammatory mediators and Foxp3 expression in different MS subtypes. The gene discussed is FOXP3; the disease is myeloid sarcoma.